nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A1—Clonidine—glaucoma	0.114	0.194	CbGbCtD
Toremifene—CYP1A2—Betaxolol—glaucoma	0.093	0.158	CbGbCtD
Toremifene—CYP3A4—Pilocarpine—glaucoma	0.0547	0.0931	CbGbCtD
Toremifene—ABCB1—Timolol—glaucoma	0.0524	0.0893	CbGbCtD
Toremifene—CYP1A2—Clonidine—glaucoma	0.051	0.0868	CbGbCtD
Toremifene—ABCB1—Clonidine—glaucoma	0.0446	0.0759	CbGbCtD
Toremifene—CYP3A4—Brinzolamide—glaucoma	0.0429	0.0731	CbGbCtD
Toremifene—CYP3A4—Dorzolamide—glaucoma	0.0414	0.0706	CbGbCtD
Toremifene—CYP3A4—Methazolamide—glaucoma	0.0369	0.0629	CbGbCtD
Toremifene—CYP3A4—Acetazolamide—glaucoma	0.0295	0.0503	CbGbCtD
Toremifene—CYP3A4—Clonidine—glaucoma	0.0267	0.0455	CbGbCtD
Toremifene—CYP1A1—Tamoxifen metabolism—CYP1B1—glaucoma	0.000676	0.0127	CbGpPWpGaD
Toremifene—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000655	0.0123	CbGpPWpGaD
Toremifene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000641	0.012	CbGpPWpGaD
Toremifene—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000633	0.0119	CbGpPWpGaD
Toremifene—CYP1A1—Estrogen metabolism—GSTM1—glaucoma	0.000611	0.0115	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000545	0.0102	CbGpPWpGaD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000536	0.00149	CcSEcCtD
Toremifene—Tremor—Pilocarpine—glaucoma	0.000536	0.00149	CcSEcCtD
Toremifene—Vertigo—Brinzolamide—glaucoma	0.000535	0.00149	CcSEcCtD
Toremifene—Pruritus—Latanoprost—glaucoma	0.000533	0.00148	CcSEcCtD
Toremifene—Rash—Diclofenamide—glaucoma	0.000533	0.00148	CcSEcCtD
Toremifene—Affect lability—Timolol—glaucoma	0.000531	0.00148	CcSEcCtD
Toremifene—Headache—Diclofenamide—glaucoma	0.00053	0.00147	CcSEcCtD
Toremifene—Insomnia—Bimatoprost—glaucoma	0.000528	0.00147	CcSEcCtD
Toremifene—Thrombocytopenia—Acetazolamide—glaucoma	0.000528	0.00147	CcSEcCtD
Toremifene—ESR1—ATF-2 transcription factor network—TGFB2—glaucoma	0.000525	0.00985	CbGpPWpGaD
Toremifene—Vomiting—Carbachol—glaucoma	0.000525	0.00146	CcSEcCtD
Toremifene—CYP1A1—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000522	0.00979	CbGpPWpGaD
Toremifene—Dyspnoea—Bimatoprost—glaucoma	0.000521	0.00145	CcSEcCtD
Toremifene—Rash—Carbachol—glaucoma	0.00052	0.00145	CcSEcCtD
Toremifene—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00052	0.00145	CcSEcCtD
Toremifene—Dermatitis—Carbachol—glaucoma	0.00052	0.00145	CcSEcCtD
Toremifene—Fatigue—Apraclonidine—glaucoma	0.000519	0.00144	CcSEcCtD
Toremifene—Weight increased—Betaxolol—glaucoma	0.000519	0.00144	CcSEcCtD
Toremifene—Oedema—Brimonidine—glaucoma	0.000517	0.00144	CcSEcCtD
Toremifene—Headache—Carbachol—glaucoma	0.000517	0.00144	CcSEcCtD
Toremifene—Chest pain—Dorzolamide—glaucoma	0.000515	0.00143	CcSEcCtD
Toremifene—Pain—Apraclonidine—glaucoma	0.000515	0.00143	CcSEcCtD
Toremifene—Constipation—Apraclonidine—glaucoma	0.000515	0.00143	CcSEcCtD
Toremifene—Chest pain—Travoprost—glaucoma	0.000513	0.00143	CcSEcCtD
Toremifene—Leukopenia—Pilocarpine—glaucoma	0.000512	0.00142	CcSEcCtD
Toremifene—Mood swings—Timolol—glaucoma	0.000511	0.00142	CcSEcCtD
Toremifene—Nausea—Carteolol—glaucoma	0.000511	0.00142	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000509	0.00142	CcSEcCtD
Toremifene—Headache—Levobunolol—glaucoma	0.000509	0.00142	CcSEcCtD
Toremifene—Nervous system disorder—Brimonidine—glaucoma	0.000507	0.00141	CcSEcCtD
Toremifene—Chest pain—Brinzolamide—glaucoma	0.000507	0.00141	CcSEcCtD
Toremifene—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000504	0.0014	CcSEcCtD
Toremifene—ESR1—FOXA1 transcription factor network—SOD1—glaucoma	0.000503	0.00944	CbGpPWpGaD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000503	0.0014	CcSEcCtD
Toremifene—Skin disorder—Brimonidine—glaucoma	0.000502	0.0014	CcSEcCtD
Toremifene—Nausea—Diclofenamide—glaucoma	0.000502	0.0014	CcSEcCtD
Toremifene—Acute coronary syndrome—Betaxolol—glaucoma	0.000502	0.0014	CcSEcCtD
Toremifene—Pain—Bimatoprost—glaucoma	0.000499	0.00139	CcSEcCtD
Toremifene—Myocardial infarction—Betaxolol—glaucoma	0.000499	0.00139	CcSEcCtD
Toremifene—Neuropathy peripheral—Betaxolol—glaucoma	0.000499	0.00139	CcSEcCtD
Toremifene—Dizziness—Latanoprost—glaucoma	0.000498	0.00139	CcSEcCtD
Toremifene—Liver function test abnormal—Timolol—glaucoma	0.000498	0.00139	CcSEcCtD
Toremifene—Vomiting—Methazolamide—glaucoma	0.000495	0.00138	CcSEcCtD
Toremifene—Oedema—Dorzolamide—glaucoma	0.000494	0.00137	CcSEcCtD
Toremifene—Oedema—Travoprost—glaucoma	0.000492	0.00137	CcSEcCtD
Toremifene—Rash—Methazolamide—glaucoma	0.000491	0.00137	CcSEcCtD
Toremifene—Dermatitis—Methazolamide—glaucoma	0.00049	0.00136	CcSEcCtD
Toremifene—Eye disorder—Clonidine—glaucoma	0.00049	0.00136	CcSEcCtD
Toremifene—Nausea—Carbachol—glaucoma	0.00049	0.00136	CcSEcCtD
Toremifene—Sweating—Betaxolol—glaucoma	0.000488	0.00136	CcSEcCtD
Toremifene—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000488	0.00914	CbGpPWpGaD
Toremifene—Headache—Methazolamide—glaucoma	0.000488	0.00136	CcSEcCtD
Toremifene—Breast disorder—Timolol—glaucoma	0.000487	0.00136	CcSEcCtD
Toremifene—Chest pain—Pilocarpine—glaucoma	0.000487	0.00135	CcSEcCtD
Toremifene—Nausea—Levobunolol—glaucoma	0.000483	0.00134	CcSEcCtD
Toremifene—Nervous system disorder—Travoprost—glaucoma	0.000482	0.00134	CcSEcCtD
Toremifene—Skin disorder—Travoprost—glaucoma	0.000478	0.00133	CcSEcCtD
Toremifene—Hyperhidrosis—Dorzolamide—glaucoma	0.000477	0.00133	CcSEcCtD
Toremifene—Nervous system disorder—Brinzolamide—glaucoma	0.000476	0.00132	CcSEcCtD
Toremifene—Angiopathy—Clonidine—glaucoma	0.000476	0.00132	CcSEcCtD
Toremifene—Rash—Latanoprost—glaucoma	0.000475	0.00132	CcSEcCtD
Toremifene—Dermatitis—Latanoprost—glaucoma	0.000475	0.00132	CcSEcCtD
Toremifene—Mediastinal disorder—Clonidine—glaucoma	0.000473	0.00132	CcSEcCtD
Toremifene—Headache—Latanoprost—glaucoma	0.000472	0.00131	CcSEcCtD
Toremifene—Skin disorder—Brinzolamide—glaucoma	0.000472	0.00131	CcSEcCtD
Toremifene—Anorexia—Dorzolamide—glaucoma	0.000471	0.00131	CcSEcCtD
Toremifene—ESR1—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.00047	0.00881	CbGpPWpGaD
Toremifene—ESR1—Nuclear Receptors—NR3C1—glaucoma	0.00047	0.00881	CbGpPWpGaD
Toremifene—Arrhythmia—Clonidine—glaucoma	0.000469	0.0013	CcSEcCtD
Toremifene—Decreased appetite—Acetazolamide—glaucoma	0.000468	0.0013	CcSEcCtD
Toremifene—Insomnia—Brimonidine—glaucoma	0.000468	0.0013	CcSEcCtD
Toremifene—Oedema—Pilocarpine—glaucoma	0.000467	0.0013	CcSEcCtD
Toremifene—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000465	0.00129	CcSEcCtD
Toremifene—Fatigue—Acetazolamide—glaucoma	0.000465	0.00129	CcSEcCtD
Toremifene—Alopecia—Clonidine—glaucoma	0.000464	0.00129	CcSEcCtD
Toremifene—Nausea—Methazolamide—glaucoma	0.000462	0.00129	CcSEcCtD
Toremifene—Dyspnoea—Brimonidine—glaucoma	0.000461	0.00128	CcSEcCtD
Toremifene—Mental disorder—Clonidine—glaucoma	0.00046	0.00128	CcSEcCtD
Toremifene—Thrombocytopenia—Pilocarpine—glaucoma	0.000457	0.00127	CcSEcCtD
Toremifene—Angina pectoris—Timolol—glaucoma	0.000454	0.00126	CcSEcCtD
Toremifene—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000453	0.00849	CbGpPWpGaD
Toremifene—Hyperhidrosis—Pilocarpine—glaucoma	0.000451	0.00126	CcSEcCtD
Toremifene—Insomnia—Dorzolamide—glaucoma	0.000447	0.00124	CcSEcCtD
Toremifene—Gastrointestinal disorder—Brimonidine—glaucoma	0.000446	0.00124	CcSEcCtD
Toremifene—Fatigue—Brimonidine—glaucoma	0.000446	0.00124	CcSEcCtD
Toremifene—Anorexia—Pilocarpine—glaucoma	0.000445	0.00124	CcSEcCtD
Toremifene—Pain—Brimonidine—glaucoma	0.000442	0.00123	CcSEcCtD
Toremifene—Dyspnoea—Dorzolamide—glaucoma	0.00044	0.00122	CcSEcCtD
Toremifene—Visual impairment—Betaxolol—glaucoma	0.00044	0.00122	CcSEcCtD
Toremifene—Insomnia—Brinzolamide—glaucoma	0.000439	0.00122	CcSEcCtD
Toremifene—Dyspnoea—Travoprost—glaucoma	0.000438	0.00122	CcSEcCtD
Toremifene—Dyspnoea—Brinzolamide—glaucoma	0.000433	0.0012	CcSEcCtD
Toremifene—Asthenia—Apraclonidine—glaucoma	0.000432	0.0012	CcSEcCtD
Toremifene—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000431	0.00808	CbGpPWpGaD
Toremifene—Vision blurred—Clonidine—glaucoma	0.00043	0.0012	CcSEcCtD
Toremifene—Decreased appetite—Dorzolamide—glaucoma	0.000429	0.00119	CcSEcCtD
Toremifene—Tremor—Clonidine—glaucoma	0.000428	0.00119	CcSEcCtD
Toremifene—Eye disorder—Betaxolol—glaucoma	0.000427	0.00119	CcSEcCtD
Toremifene—Pruritus—Apraclonidine—glaucoma	0.000426	0.00119	CcSEcCtD
Toremifene—Fatigue—Dorzolamide—glaucoma	0.000426	0.00118	CcSEcCtD
Toremifene—Gastrointestinal disorder—Travoprost—glaucoma	0.000425	0.00118	CcSEcCtD
Toremifene—Fatigue—Travoprost—glaucoma	0.000424	0.00118	CcSEcCtD
Toremifene—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000422	0.00792	CbGpPWpGaD
Toremifene—Pain—Dorzolamide—glaucoma	0.000422	0.00117	CcSEcCtD
Toremifene—Insomnia—Pilocarpine—glaucoma	0.000422	0.00117	CcSEcCtD
Toremifene—Decreased appetite—Brinzolamide—glaucoma	0.000422	0.00117	CcSEcCtD
Toremifene—Pain—Travoprost—glaucoma	0.000421	0.00117	CcSEcCtD
Toremifene—Constipation—Travoprost—glaucoma	0.000421	0.00117	CcSEcCtD
Toremifene—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000419	0.00117	CcSEcCtD
Toremifene—Asthenia—Bimatoprost—glaucoma	0.000419	0.00117	CcSEcCtD
Toremifene—Fatigue—Brinzolamide—glaucoma	0.000419	0.00116	CcSEcCtD
Toremifene—Dyspnoea—Pilocarpine—glaucoma	0.000416	0.00116	CcSEcCtD
Toremifene—Pain—Brinzolamide—glaucoma	0.000415	0.00116	CcSEcCtD
Toremifene—Angiopathy—Betaxolol—glaucoma	0.000414	0.00115	CcSEcCtD
Toremifene—Pruritus—Bimatoprost—glaucoma	0.000413	0.00115	CcSEcCtD
Toremifene—Mediastinal disorder—Betaxolol—glaucoma	0.000412	0.00114	CcSEcCtD
Toremifene—Chills—Betaxolol—glaucoma	0.00041	0.00114	CcSEcCtD
Toremifene—Arrhythmia—Betaxolol—glaucoma	0.000408	0.00113	CcSEcCtD
Toremifene—Decreased appetite—Pilocarpine—glaucoma	0.000406	0.00113	CcSEcCtD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000404	0.00757	CbGpPWpGaD
Toremifene—Alopecia—Betaxolol—glaucoma	0.000404	0.00112	CcSEcCtD
Toremifene—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000403	0.00112	CcSEcCtD
Toremifene—Mental disorder—Betaxolol—glaucoma	0.0004	0.00111	CcSEcCtD
Toremifene—Pain—Pilocarpine—glaucoma	0.000399	0.00111	CcSEcCtD
Toremifene—Constipation—Pilocarpine—glaucoma	0.000399	0.00111	CcSEcCtD
Toremifene—Sweating—Timolol—glaucoma	0.000398	0.00111	CcSEcCtD
Toremifene—Dizziness—Apraclonidine—glaucoma	0.000398	0.00111	CcSEcCtD
Toremifene—Malnutrition—Betaxolol—glaucoma	0.000398	0.00111	CcSEcCtD
Toremifene—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.00039	0.00731	CbGpPWpGaD
Toremifene—Chest pain—Clonidine—glaucoma	0.000389	0.00108	CcSEcCtD
Toremifene—Asthenia—Acetazolamide—glaucoma	0.000387	0.00108	CcSEcCtD
Toremifene—Dizziness—Bimatoprost—glaucoma	0.000386	0.00107	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000386	0.00107	CcSEcCtD
Toremifene—Vomiting—Apraclonidine—glaucoma	0.000383	0.00107	CcSEcCtD
Toremifene—Dermatitis—Apraclonidine—glaucoma	0.000379	0.00106	CcSEcCtD
Toremifene—Headache—Apraclonidine—glaucoma	0.000377	0.00105	CcSEcCtD
Toremifene—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000376	0.00706	CbGpPWpGaD
Toremifene—Vision blurred—Betaxolol—glaucoma	0.000375	0.00104	CcSEcCtD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.000373	0.00699	CbGpPWpGaD
Toremifene—Oedema—Clonidine—glaucoma	0.000373	0.00104	CcSEcCtD
Toremifene—Tremor—Betaxolol—glaucoma	0.000372	0.00104	CcSEcCtD
Toremifene—ESR1—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000371	0.00696	CbGpPWpGaD
Toremifene—Asthenia—Brimonidine—glaucoma	0.000371	0.00103	CcSEcCtD
Toremifene—Rash—Bimatoprost—glaucoma	0.000368	0.00102	CcSEcCtD
Toremifene—Dermatitis—Bimatoprost—glaucoma	0.000368	0.00102	CcSEcCtD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000367	0.00688	CbGpPWpGaD
Toremifene—Pruritus—Brimonidine—glaucoma	0.000366	0.00102	CcSEcCtD
Toremifene—Headache—Bimatoprost—glaucoma	0.000366	0.00102	CcSEcCtD
Toremifene—Nervous system disorder—Clonidine—glaucoma	0.000365	0.00102	CcSEcCtD
Toremifene—Thrombocytopenia—Clonidine—glaucoma	0.000365	0.00102	CcSEcCtD
Toremifene—Skin disorder—Clonidine—glaucoma	0.000362	0.00101	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000361	0.00677	CbGpPWpGaD
Toremifene—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000361	0.00677	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000361	0.00677	CbGpPWpGaD
Toremifene—Hyperhidrosis—Clonidine—glaucoma	0.00036	0.001	CcSEcCtD
Toremifene—Visual impairment—Timolol—glaucoma	0.00036	0.001	CcSEcCtD
Toremifene—Nausea—Apraclonidine—glaucoma	0.000358	0.000995	CcSEcCtD
Toremifene—Vertigo—Betaxolol—glaucoma	0.000357	0.000994	CcSEcCtD
Toremifene—Dizziness—Acetazolamide—glaucoma	0.000356	0.000991	CcSEcCtD
Toremifene—Anorexia—Clonidine—glaucoma	0.000355	0.000988	CcSEcCtD
Toremifene—Asthenia—Dorzolamide—glaucoma	0.000354	0.000986	CcSEcCtD
Toremifene—Asthenia—Travoprost—glaucoma	0.000353	0.000982	CcSEcCtD
Toremifene—Pruritus—Dorzolamide—glaucoma	0.000349	0.000972	CcSEcCtD
Toremifene—Eye disorder—Timolol—glaucoma	0.000349	0.00097	CcSEcCtD
Toremifene—Asthenia—Brinzolamide—glaucoma	0.000348	0.000969	CcSEcCtD
Toremifene—Pruritus—Travoprost—glaucoma	0.000348	0.000968	CcSEcCtD
Toremifene—Nausea—Bimatoprost—glaucoma	0.000347	0.000965	CcSEcCtD
Toremifene—Pruritus—Brinzolamide—glaucoma	0.000344	0.000956	CcSEcCtD
Toremifene—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.000344	0.00644	CbGpPWpGaD
Toremifene—Vomiting—Acetazolamide—glaucoma	0.000343	0.000953	CcSEcCtD
Toremifene—Dizziness—Brimonidine—glaucoma	0.000342	0.000951	CcSEcCtD
Toremifene—Angiopathy—Timolol—glaucoma	0.000339	0.000942	CcSEcCtD
Toremifene—Chest pain—Betaxolol—glaucoma	0.000338	0.000942	CcSEcCtD
Toremifene—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000338	0.00633	CbGpPWpGaD
Toremifene—Headache—Acetazolamide—glaucoma	0.000338	0.000939	CcSEcCtD
Toremifene—Insomnia—Clonidine—glaucoma	0.000337	0.000938	CcSEcCtD
Toremifene—Mediastinal disorder—Timolol—glaucoma	0.000336	0.000935	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000336	0.000935	CcSEcCtD
Toremifene—Asthenia—Pilocarpine—glaucoma	0.000335	0.000931	CcSEcCtD
Toremifene—Arrhythmia—Timolol—glaucoma	0.000333	0.000927	CcSEcCtD
Toremifene—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000333	0.00624	CbGpPWpGaD
Toremifene—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000333	0.00624	CbGpPWpGaD
Toremifene—Dyspnoea—Clonidine—glaucoma	0.000332	0.000924	CcSEcCtD
Toremifene—Pruritus—Pilocarpine—glaucoma	0.00033	0.000918	CcSEcCtD
Toremifene—Alopecia—Timolol—glaucoma	0.00033	0.000917	CcSEcCtD
Toremifene—Mental disorder—Timolol—glaucoma	0.000327	0.000909	CcSEcCtD
Toremifene—Dizziness—Dorzolamide—glaucoma	0.000327	0.000909	CcSEcCtD
Toremifene—Rash—Brimonidine—glaucoma	0.000326	0.000907	CcSEcCtD
Toremifene—Dermatitis—Brimonidine—glaucoma	0.000326	0.000906	CcSEcCtD
Toremifene—Dizziness—Travoprost—glaucoma	0.000325	0.000905	CcSEcCtD
Toremifene—Malnutrition—Timolol—glaucoma	0.000325	0.000903	CcSEcCtD
Toremifene—Oedema—Betaxolol—glaucoma	0.000324	0.000903	CcSEcCtD
Toremifene—Headache—Brimonidine—glaucoma	0.000324	0.000901	CcSEcCtD
Toremifene—Decreased appetite—Clonidine—glaucoma	0.000324	0.000901	CcSEcCtD
Toremifene—Gastrointestinal disorder—Clonidine—glaucoma	0.000322	0.000895	CcSEcCtD
Toremifene—Fatigue—Clonidine—glaucoma	0.000321	0.000894	CcSEcCtD
Toremifene—Dizziness—Brinzolamide—glaucoma	0.000321	0.000893	CcSEcCtD
Toremifene—Nausea—Acetazolamide—glaucoma	0.00032	0.00089	CcSEcCtD
Toremifene—Constipation—Clonidine—glaucoma	0.000319	0.000887	CcSEcCtD
Toremifene—Pain—Clonidine—glaucoma	0.000319	0.000887	CcSEcCtD
Toremifene—Nervous system disorder—Betaxolol—glaucoma	0.000318	0.000885	CcSEcCtD
Toremifene—Thrombocytopenia—Betaxolol—glaucoma	0.000318	0.000884	CcSEcCtD
Toremifene—Skin disorder—Betaxolol—glaucoma	0.000315	0.000877	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—EDN1—glaucoma	0.000315	0.00591	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.000314	0.00589	CbGpPWpGaD
Toremifene—Vomiting—Dorzolamide—glaucoma	0.000314	0.000874	CcSEcCtD
Toremifene—Hyperhidrosis—Betaxolol—glaucoma	0.000314	0.000873	CcSEcCtD
Toremifene—Rash—Dorzolamide—glaucoma	0.000311	0.000866	CcSEcCtD
Toremifene—Dermatitis—Dorzolamide—glaucoma	0.000311	0.000865	CcSEcCtD
Toremifene—Rash—Travoprost—glaucoma	0.00031	0.000863	CcSEcCtD
Toremifene—Dermatitis—Travoprost—glaucoma	0.00031	0.000862	CcSEcCtD
Toremifene—Headache—Dorzolamide—glaucoma	0.000309	0.000861	CcSEcCtD
Toremifene—Anorexia—Betaxolol—glaucoma	0.000309	0.00086	CcSEcCtD
Toremifene—Vomiting—Brinzolamide—glaucoma	0.000309	0.000859	CcSEcCtD
Toremifene—Dizziness—Pilocarpine—glaucoma	0.000309	0.000858	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—MMP2—glaucoma	0.000308	0.00578	CbGpPWpGaD
Toremifene—Headache—Travoprost—glaucoma	0.000308	0.000857	CcSEcCtD
Toremifene—Nausea—Brimonidine—glaucoma	0.000307	0.000855	CcSEcCtD
Toremifene—Rash—Brinzolamide—glaucoma	0.000306	0.000852	CcSEcCtD
Toremifene—Vision blurred—Timolol—glaucoma	0.000306	0.000851	CcSEcCtD
Toremifene—Dermatitis—Brinzolamide—glaucoma	0.000306	0.000851	CcSEcCtD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000306	0.00573	CbGpPWpGaD
Toremifene—Headache—Brinzolamide—glaucoma	0.000304	0.000846	CcSEcCtD
Toremifene—ESR1—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000302	0.00566	CbGpPWpGaD
Toremifene—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000301	0.00564	CbGpPWpGaD
Toremifene—Vomiting—Pilocarpine—glaucoma	0.000297	0.000825	CcSEcCtD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000296	0.00554	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.000295	0.00552	CbGpPWpGaD
Toremifene—Rash—Pilocarpine—glaucoma	0.000294	0.000819	CcSEcCtD
Toremifene—Dermatitis—Pilocarpine—glaucoma	0.000294	0.000818	CcSEcCtD
Toremifene—Insomnia—Betaxolol—glaucoma	0.000293	0.000816	CcSEcCtD
Toremifene—Nausea—Dorzolamide—glaucoma	0.000293	0.000816	CcSEcCtD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000293	0.0055	CbGpPWpGaD
Toremifene—Headache—Pilocarpine—glaucoma	0.000292	0.000813	CcSEcCtD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000292	0.00548	CbGpPWpGaD
Toremifene—Nausea—Travoprost—glaucoma	0.000292	0.000813	CcSEcCtD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000292	0.00547	CbGpPWpGaD
Toremifene—Vertigo—Timolol—glaucoma	0.000292	0.000812	CcSEcCtD
Toremifene—Dyspnoea—Betaxolol—glaucoma	0.000289	0.000805	CcSEcCtD
Toremifene—Nausea—Brinzolamide—glaucoma	0.000288	0.000802	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.000288	0.0054	CbGpPWpGaD
Toremifene—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000288	0.0054	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.000283	0.0053	CbGpPWpGaD
Toremifene—Decreased appetite—Betaxolol—glaucoma	0.000282	0.000785	CcSEcCtD
Toremifene—Gastrointestinal disorder—Betaxolol—glaucoma	0.00028	0.000779	CcSEcCtD
Toremifene—Fatigue—Betaxolol—glaucoma	0.00028	0.000778	CcSEcCtD
Toremifene—Pain—Betaxolol—glaucoma	0.000277	0.000772	CcSEcCtD
Toremifene—Constipation—Betaxolol—glaucoma	0.000277	0.000772	CcSEcCtD
Toremifene—Nausea—Pilocarpine—glaucoma	0.000277	0.000771	CcSEcCtD
Toremifene—Chest pain—Timolol—glaucoma	0.000277	0.000769	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000275	0.000764	CcSEcCtD
Toremifene—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000269	0.00505	CbGpPWpGaD
Toremifene—Asthenia—Clonidine—glaucoma	0.000267	0.000744	CcSEcCtD
Toremifene—Oedema—Timolol—glaucoma	0.000265	0.000737	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.000265	0.00496	CbGpPWpGaD
Toremifene—Pruritus—Clonidine—glaucoma	0.000264	0.000733	CcSEcCtD
Toremifene—Nervous system disorder—Timolol—glaucoma	0.00026	0.000723	CcSEcCtD
Toremifene—Skin disorder—Timolol—glaucoma	0.000257	0.000716	CcSEcCtD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000256	0.00481	CbGpPWpGaD
Toremifene—Hyperhidrosis—Timolol—glaucoma	0.000256	0.000713	CcSEcCtD
Toremifene—Anorexia—Timolol—glaucoma	0.000253	0.000703	CcSEcCtD
Toremifene—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.000249	0.00467	CbGpPWpGaD
Toremifene—Dizziness—Clonidine—glaucoma	0.000246	0.000686	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000246	0.0046	CbGpPWpGaD
Toremifene—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000241	0.00452	CbGpPWpGaD
Toremifene—Insomnia—Timolol—glaucoma	0.00024	0.000667	CcSEcCtD
Toremifene—Vomiting—Clonidine—glaucoma	0.000237	0.000659	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000237	0.00444	CbGpPWpGaD
Toremifene—Dyspnoea—Timolol—glaucoma	0.000236	0.000657	CcSEcCtD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000236	0.00443	CbGpPWpGaD
Toremifene—Rash—Clonidine—glaucoma	0.000235	0.000654	CcSEcCtD
Toremifene—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.000235	0.0044	CbGpPWpGaD
Toremifene—Dermatitis—Clonidine—glaucoma	0.000235	0.000653	CcSEcCtD
Toremifene—Headache—Clonidine—glaucoma	0.000233	0.000649	CcSEcCtD
Toremifene—Asthenia—Betaxolol—glaucoma	0.000233	0.000648	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000233	0.00436	CbGpPWpGaD
Toremifene—Decreased appetite—Timolol—glaucoma	0.00023	0.000641	CcSEcCtD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00023	0.00432	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00023	0.00432	CbGpPWpGaD
Toremifene—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.00023	0.00432	CbGpPWpGaD
Toremifene—Pruritus—Betaxolol—glaucoma	0.00023	0.000639	CcSEcCtD
Toremifene—Gastrointestinal disorder—Timolol—glaucoma	0.000229	0.000637	CcSEcCtD
Toremifene—Fatigue—Timolol—glaucoma	0.000229	0.000636	CcSEcCtD
Toremifene—Pain—Timolol—glaucoma	0.000227	0.000631	CcSEcCtD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000226	0.00424	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—BAD—glaucoma	0.000226	0.00424	CbGpPWpGaD
Toremifene—Nausea—Clonidine—glaucoma	0.000221	0.000616	CcSEcCtD
Toremifene—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000219	0.00411	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000215	0.00404	CbGpPWpGaD
Toremifene—Dizziness—Betaxolol—glaucoma	0.000215	0.000597	CcSEcCtD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000214	0.00401	CbGpPWpGaD
Toremifene—Vomiting—Betaxolol—glaucoma	0.000206	0.000574	CcSEcCtD
Toremifene—Rash—Betaxolol—glaucoma	0.000205	0.000569	CcSEcCtD
Toremifene—Dermatitis—Betaxolol—glaucoma	0.000204	0.000569	CcSEcCtD
Toremifene—Headache—Betaxolol—glaucoma	0.000203	0.000565	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000194	0.00363	CbGpPWpGaD
Toremifene—Nausea—Betaxolol—glaucoma	0.000193	0.000536	CcSEcCtD
Toremifene—Asthenia—Timolol—glaucoma	0.00019	0.000529	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000188	0.00352	CbGpPWpGaD
Toremifene—Pruritus—Timolol—glaucoma	0.000188	0.000522	CcSEcCtD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000186	0.00349	CbGpPWpGaD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000184	0.00344	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000182	0.00341	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.000182	0.00341	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	0.00018	0.00337	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000178	0.00333	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000176	0.0033	CbGpPWpGaD
Toremifene—Dizziness—Timolol—glaucoma	0.000175	0.000488	CcSEcCtD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000175	0.00328	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000172	0.00322	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.00017	0.00319	CbGpPWpGaD
Toremifene—Vomiting—Timolol—glaucoma	0.000169	0.000469	CcSEcCtD
Toremifene—Rash—Timolol—glaucoma	0.000167	0.000465	CcSEcCtD
Toremifene—Dermatitis—Timolol—glaucoma	0.000167	0.000464	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000166	0.00312	CbGpPWpGaD
Toremifene—Headache—Timolol—glaucoma	0.000166	0.000462	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000166	0.00311	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000163	0.00305	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00016	0.00301	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00016	0.00299	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GSTT1—glaucoma	0.000158	0.00296	CbGpPWpGaD
Toremifene—Nausea—Timolol—glaucoma	0.000157	0.000438	CcSEcCtD
Toremifene—ESR1—LKB1 signaling events—TP53—glaucoma	0.000154	0.00289	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000154	0.00289	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000154	0.00289	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000154	0.00289	CbGpPWpGaD
Toremifene—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000152	0.00285	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000151	0.00283	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL1A—glaucoma	0.00015	0.00282	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000147	0.00276	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000146	0.00274	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000144	0.00269	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000143	0.00268	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000142	0.00266	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—FAS—glaucoma	0.000134	0.00251	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—C3—glaucoma	0.000132	0.00248	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000129	0.00242	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—BAD—glaucoma	0.000128	0.00241	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000128	0.0024	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP1B1—glaucoma	0.000126	0.00236	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000125	0.00234	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000124	0.00232	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000121	0.00227	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000117	0.0022	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000117	0.00219	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000116	0.00218	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000113	0.00212	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NARFL—glaucoma	0.000111	0.00207	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA5A—glaucoma	0.000111	0.00207	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.00011	0.00206	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.00011	0.00206	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.00011	0.00205	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000108	0.00203	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000107	0.00201	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LRP12—glaucoma	0.000106	0.00198	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.000105	0.00196	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000104	0.00194	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000101	0.00189	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GSTM1—glaucoma	0.000101	0.00188	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	9.91e-05	0.00186	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	9.83e-05	0.00184	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	9.83e-05	0.00184	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	9.71e-05	0.00182	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	8.94e-05	0.00168	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA5A—glaucoma	8.83e-05	0.00166	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NARFL—glaucoma	8.83e-05	0.00166	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.45e-05	0.00158	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	8.17e-05	0.00153	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP1B1—glaucoma	8.02e-05	0.0015	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	7.91e-05	0.00148	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.87e-05	0.00147	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.78e-05	0.00146	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.76e-05	0.00146	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.73e-05	0.00145	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	7.67e-05	0.00144	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.49e-05	0.0014	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	7.48e-05	0.0014	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.45e-05	0.0014	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—OPN4—glaucoma	7.33e-05	0.00137	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	7.31e-05	0.00137	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.23e-05	0.00135	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA5A—glaucoma	7.05e-05	0.00132	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NARFL—glaucoma	7.05e-05	0.00132	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	7.01e-05	0.00131	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	7.01e-05	0.00131	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HEYL—glaucoma	6.82e-05	0.00128	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.64e-05	0.00125	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.62e-05	0.00124	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTGFR—glaucoma	6.6e-05	0.00124	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	6.41e-05	0.0012	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTM1—glaucoma	6.41e-05	0.0012	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	6.32e-05	0.00118	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.2e-05	0.00116	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.19e-05	0.00116	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.1e-05	0.00114	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—glaucoma	5.69e-05	0.00107	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.66e-05	0.00106	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	5.65e-05	0.00106	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA5A—glaucoma	5.44e-05	0.00102	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NARFL—glaucoma	5.44e-05	0.00102	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA1—glaucoma	5.4e-05	0.00101	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.31e-05	0.000995	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.29e-05	0.000991	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CTSA—glaucoma	5.23e-05	0.00098	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RPTOR—glaucoma	5.17e-05	0.000968	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NCK2—glaucoma	5e-05	0.000938	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.95e-05	0.000927	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA2—glaucoma	4.94e-05	0.000926	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.88e-05	0.000914	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.83e-05	0.000905	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.83e-05	0.000905	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.68e-05	0.000878	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA1—glaucoma	4.31e-05	0.000809	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HDAC9—glaucoma	4.25e-05	0.000797	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CTSA—glaucoma	4.18e-05	0.000783	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.16e-05	0.00078	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA2—glaucoma	3.95e-05	0.000739	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.94e-05	0.000739	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CDKN2B—glaucoma	3.52e-05	0.000659	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TXN—glaucoma	3.48e-05	0.000652	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA1—glaucoma	3.44e-05	0.000645	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CTSA—glaucoma	3.33e-05	0.000625	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SMO—glaucoma	3.33e-05	0.000624	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.28e-05	0.000614	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.18e-05	0.000595	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA2—glaucoma	3.15e-05	0.00059	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.15e-05	0.00059	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NR3C1—glaucoma	3.09e-05	0.000579	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.08e-05	0.000577	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.08e-05	0.000577	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NTRK2—glaucoma	3.04e-05	0.000571	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.81e-05	0.000527	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TXN—glaucoma	2.78e-05	0.000521	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTT1—glaucoma	2.7e-05	0.000506	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA1—glaucoma	2.66e-05	0.000498	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NGFR—glaucoma	2.61e-05	0.00049	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CTSA—glaucoma	2.57e-05	0.000482	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NTRK1—glaucoma	2.48e-05	0.000465	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.48e-05	0.000464	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA2—glaucoma	2.43e-05	0.000456	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN2B—glaucoma	2.29e-05	0.000429	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TXN—glaucoma	2.22e-05	0.000416	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDN1—glaucoma	2.19e-05	0.000411	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.18e-05	0.000408	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTT1—glaucoma	2.16e-05	0.000404	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCA1—glaucoma	2.15e-05	0.000403	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP1B1—glaucoma	2.15e-05	0.000403	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.02e-05	0.00038	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NGF—glaucoma	2.02e-05	0.000378	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.01e-05	0.000376	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—C3—glaucoma	1.92e-05	0.000359	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—glaucoma	1.79e-05	0.000335	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CAV1—glaucoma	1.77e-05	0.000332	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—glaucoma	1.72e-05	0.000322	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—glaucoma	1.72e-05	0.000322	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCA1—glaucoma	1.72e-05	0.000322	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1B1—glaucoma	1.72e-05	0.000322	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TXN—glaucoma	1.71e-05	0.000321	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FN1—glaucoma	1.68e-05	0.000316	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BAD—glaucoma	1.66e-05	0.000312	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—glaucoma	1.52e-05	0.000285	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—glaucoma	1.41e-05	0.000265	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAV1—glaucoma	1.4e-05	0.000263	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.39e-05	0.00026	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—glaucoma	1.37e-05	0.000257	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCA1—glaucoma	1.37e-05	0.000257	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1B1—glaucoma	1.37e-05	0.000257	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—glaucoma	1.34e-05	0.000251	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—glaucoma	1.33e-05	0.000249	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—glaucoma	1.21e-05	0.000227	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—glaucoma	1.16e-05	0.000217	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—glaucoma	1.13e-05	0.000212	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAV1—glaucoma	1.12e-05	0.00021	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—glaucoma	1.1e-05	0.000205	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—glaucoma	1.07e-05	0.000201	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—glaucoma	1.06e-05	0.000199	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCA1—glaucoma	1.06e-05	0.000198	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1B1—glaucoma	1.06e-05	0.000198	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—glaucoma	9.69e-06	0.000182	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—glaucoma	9.69e-06	0.000182	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—glaucoma	9.63e-06	0.000181	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—glaucoma	9.02e-06	0.000169	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAV1—glaucoma	8.93e-06	0.000167	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—glaucoma	8.46e-06	0.000159	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—glaucoma	8.46e-06	0.000159	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—glaucoma	7.74e-06	0.000145	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—glaucoma	7.47e-06	0.00014	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—glaucoma	7.28e-06	0.000136	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—glaucoma	6.96e-06	0.00013	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAV1—glaucoma	6.89e-06	0.000129	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—glaucoma	6.76e-06	0.000127	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—glaucoma	6.18e-06	0.000116	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—glaucoma	5.21e-06	9.77e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—glaucoma	4.77e-06	8.94e-05	CbGpPWpGaD
